ET8-26920-24254
3 vaccinations
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 16-20
- ZIP prefix
- 210 / MD
- Registered
- 2021-12-13
- Relationship
- Child or adolescent in my care
- Guardian
- LAA-30897-26266
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Dose 1 — Pfizer-BioNTech
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-12-11
Dose 3 — Pfizer-BioNTech
-
2021-12-13
Registered in v-safe
- 2021-12-13
- 2021-12-14
-
2021-12-15
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Lymphadenopathy — Feeling: GoodFree text: Forgot to report he did have ipsilateral axillary lymphadenopathy about 36 hrs post that lasted for a day or soMedDRA releases: 2024-11 · check-in free text available
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-25
- 2022-01-03
- 2022-01-08
- 2022-01-15
- 2022-01-22
- 2022-03-12
- 2022-06-11
-
2022-12-11
Survey response — 12 months, dose 3, dependentMedDRA: Circadian rhythm sleep disorder, Cognitive disorder, Disturbance in attention, Exercise tolerance decreased, Fatigue, Hypersomnia, Language disorder, Memory impairment, Office visit, Pre-existing disease, Rehabilitation therapy, Speech-language therapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Long COVID- significant circadian rhythm disruption, excessive sleep, fatigue, exercise intolerance, difficulty with attention, concentration and memory, and cognitive impairment especially in the domain of language. · Healthcare visit (other): Sleep study, physical medicine and rehab for energy conservation, speech therapy, memory clinic, psychiatry, and pulmonary/sleep medicine specialistMedDRA releases: 2024-11 · check-in free text available
-
2022-12-11
Report sent to call center — 12 months, dose 3, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | No |
| 2 | 2021-04-23 | Pfizer-BioNTech | No |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 10 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Forgot to report he did have ipsilateral axillary lymphadenopathy about 36 hrs post that lasted for a day or so
Release 12 — 12 months, dose 3, dependent
Symptoms: Long COVID- significant circadian rhythm disruption, excessive sleep, fatigue, exercise intolerance, difficulty with attention, concentration and memory, and cognitive impairment especially in the domain of language.
Healthcare visit (other): Sleep study, physical medicine and rehab for energy conservation, speech therapy, memory clinic, psychiatry, and pulmonary/sleep medicine specialist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Rehabilitation therapy | · | · | ✓ |
| HCVO | Speech-language therapy | · | · | ✓ |
| SD | Circadian rhythm sleep disorder | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Exercise tolerance decreased | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Hypersomnia | · | · | ✓ |
| SD | Language disorder | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release